...Operator Ladies and gentlemen, thank you for standing by, and welcome to Phathom Pharmaceuticals Phase III PHALCON-HP Top Line Trial Results Conference Call. (Operator Instructions) I would now like to hand the conference over to Todd Branning, Phathom's Chief Financial Officer. Thank you. Please go ahead, sir. Todd Branning Good afternoon, and thank you for joining us. My name is Todd Branning, and I am Phathom's Chief Financial Officer. Today is a very important day for Phathom, and we're excited to discuss the results from our PHALCON-HP Phase III trial that we shared earlier and to answer questions you have regarding the data. As a housekeeping item, before we begin the meeting, I want to make you aware that at the end of today's presentations, we will hold a Q&A session with our presenters, Terrie Curran, our President and Chief Executive Officer; and Azmi Nabulsi, our Chief Operating Officer; as well as other members of our leadership team; Martin Gilligan, our Chief Commercial Officer;...
